PMC:7289100 / 15486-15777 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T226","span":{"begin":120,"end":130},"obj":"Disease"},{"id":"T227","span":{"begin":135,"end":163},"obj":"Disease"},{"id":"T228","span":{"begin":168,"end":171},"obj":"Disease"}],"attributes":[{"id":"A226","pred":"mondo_id","subj":"T226","obj":"http://purl.obolibrary.org/obo/MONDO_0000831"},{"id":"A227","pred":"mondo_id","subj":"T227","obj":"http://purl.obolibrary.org/obo/MONDO_0015939"},{"id":"A228","pred":"mondo_id","subj":"T228","obj":"http://purl.obolibrary.org/obo/MONDO_0017278"},{"id":"A229","pred":"mondo_id","subj":"T228","obj":"http://purl.obolibrary.org/obo/MONDO_0007140"}],"text":"It is in fact known that antibodies directed to domain 1 of the b2GPI molecule are associated with an increased risk of thrombosis (in systemic autoimmune diseases and APS) [57] while antibodies directed to other parts of the molecule, such as domain 4/5, can be regarded as “innocent” [58]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T135","span":{"begin":251,"end":254},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"}],"text":"It is in fact known that antibodies directed to domain 1 of the b2GPI molecule are associated with an increased risk of thrombosis (in systemic autoimmune diseases and APS) [57] while antibodies directed to other parts of the molecule, such as domain 4/5, can be regarded as “innocent” [58]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T77","span":{"begin":70,"end":78},"obj":"Chemical"},{"id":"T78","span":{"begin":168,"end":171},"obj":"Chemical"},{"id":"T79","span":{"begin":226,"end":234},"obj":"Chemical"}],"attributes":[{"id":"A77","pred":"chebi_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"},{"id":"A78","pred":"chebi_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/CHEBI_17709"},{"id":"A79","pred":"chebi_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"}],"text":"It is in fact known that antibodies directed to domain 1 of the b2GPI molecule are associated with an increased risk of thrombosis (in systemic autoimmune diseases and APS) [57] while antibodies directed to other parts of the molecule, such as domain 4/5, can be regarded as “innocent” [58]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T119","span":{"begin":144,"end":163},"obj":"Phenotype"}],"attributes":[{"id":"A119","pred":"hp_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/HP_0002960"}],"text":"It is in fact known that antibodies directed to domain 1 of the b2GPI molecule are associated with an increased risk of thrombosis (in systemic autoimmune diseases and APS) [57] while antibodies directed to other parts of the molecule, such as domain 4/5, can be regarded as “innocent” [58]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T101","span":{"begin":0,"end":291},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"It is in fact known that antibodies directed to domain 1 of the b2GPI molecule are associated with an increased risk of thrombosis (in systemic autoimmune diseases and APS) [57] while antibodies directed to other parts of the molecule, such as domain 4/5, can be regarded as “innocent” [58]."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T269","span":{"begin":25,"end":35},"obj":"GO:0042571"},{"id":"T270","span":{"begin":48,"end":54},"obj":"SO:0000417"},{"id":"T271","span":{"begin":70,"end":78},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T272","span":{"begin":120,"end":130},"obj":"GO:0007596"},{"id":"T273","span":{"begin":144,"end":154},"obj":"UBERON:0002405"},{"id":"T274","span":{"begin":168,"end":171},"obj":"PR:000003015"},{"id":"T275","span":{"begin":184,"end":194},"obj":"GO:0042571"},{"id":"T276","span":{"begin":226,"end":234},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T277","span":{"begin":244,"end":250},"obj":"SO:0000417"},{"id":"T49028","span":{"begin":25,"end":35},"obj":"GO:0042571"},{"id":"T32383","span":{"begin":48,"end":54},"obj":"SO:0000417"},{"id":"T48984","span":{"begin":70,"end":78},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T85835","span":{"begin":120,"end":130},"obj":"GO:0007596"},{"id":"T28493","span":{"begin":144,"end":154},"obj":"UBERON:0002405"},{"id":"T90350","span":{"begin":168,"end":171},"obj":"PR:000003015"},{"id":"T66679","span":{"begin":184,"end":194},"obj":"GO:0042571"},{"id":"T94265","span":{"begin":226,"end":234},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T41847","span":{"begin":244,"end":250},"obj":"SO:0000417"}],"text":"It is in fact known that antibodies directed to domain 1 of the b2GPI molecule are associated with an increased risk of thrombosis (in systemic autoimmune diseases and APS) [57] while antibodies directed to other parts of the molecule, such as domain 4/5, can be regarded as “innocent” [58]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"542","span":{"begin":64,"end":69},"obj":"Gene"},{"id":"562","span":{"begin":120,"end":130},"obj":"Disease"},{"id":"563","span":{"begin":144,"end":163},"obj":"Disease"},{"id":"564","span":{"begin":168,"end":171},"obj":"Disease"}],"attributes":[{"id":"A542","pred":"tao:has_database_id","subj":"542","obj":"Gene:350"},{"id":"A562","pred":"tao:has_database_id","subj":"562","obj":"MESH:D013927"},{"id":"A563","pred":"tao:has_database_id","subj":"563","obj":"MESH:D001327"},{"id":"A564","pred":"tao:has_database_id","subj":"564","obj":"MESH:D016884"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"It is in fact known that antibodies directed to domain 1 of the b2GPI molecule are associated with an increased risk of thrombosis (in systemic autoimmune diseases and APS) [57] while antibodies directed to other parts of the molecule, such as domain 4/5, can be regarded as “innocent” [58]."}

{"project":"2_test","denotations":[{"id":"32535093-25645395-4828872","span":{"begin":174,"end":176},"obj":"25645395"}],"text":"It is in fact known that antibodies directed to domain 1 of the b2GPI molecule are associated with an increased risk of thrombosis (in systemic autoimmune diseases and APS) [57] while antibodies directed to other parts of the molecule, such as domain 4/5, can be regarded as “innocent” [58]."}